Camu et al., 1996 - Google Patents
Timing of perioperative non-steroidal anti-inflammatory drug treatmentCamu et al., 1996
- Document ID
- 18198192439545951797
- Author
- Camu F
- Vanlersberghe C
- Lauwers M
- Publication year
- Publication venue
- Acta Anaesthesiologica Belgica
External Links
Snippet
The time of non-steroidal antiinflammatory drug (NSAID) administration may be clinically important because their onset of effect may be delayed by 30-60 minutes while their opioid sparing effect is not apparent until 4 hours after administration. These findings can be …
- 239000000041 non-steroidal anti-inflammatory agent 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-arylpropionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McCormack et al. | Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs: a survey of their analgesic efficacy | |
| Saraghi et al. | Three newly approved analgesics: an update | |
| Lawand et al. | Blockade of joint inflammation and secondary hyperalgesia by L-NAME, a nitric oxide synthase inhibitor | |
| EP1177793A8 (en) | Inhalable medicinal aerosol composition for pain treatment or prevention | |
| WO2003080022A3 (en) | Analgesics for nasal administration | |
| Binning | Nimesulide in the treatment of postoperative pain: a double-blind, comparative study in patients undergoing arthroscopic knee surgery | |
| WO2008157103A3 (en) | Modified release solid or semi-solid dosage forms | |
| JPS61501913A (en) | Cough/cold combination drugs containing non-steroidal anti-inflammatory drugs | |
| Groudine et al. | Use of intravenous acetaminophen in the treatment of postoperative pain | |
| Anderson | The Opioid Wars—CON: The risks of opioids for pain management outweigh the benefits | |
| Camu et al. | Timing of perioperative non-steroidal anti-inflammatory drug treatment | |
| Widnell et al. | Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations | |
| White | Changing role of COX-2 inhibitors in the perioperative period: is parecoxib really the answer? | |
| Chang et al. | Irreversible ischemic hand following intraarterial injection of zolpidem powder | |
| Shah et al. | Prospective, double-blind randomized study of comparison of analgesic efficacy of parenteral paracetamol and diclofenac for postoperative pain relief | |
| Romero‐Sandoval et al. | Nitroparacetamol (NCX‐701) and Pain: First in a Series of Novel Analgesics | |
| US4730007A (en) | Novel analgesic compositions | |
| WO2005107467A3 (en) | Compositions including opioids and methods of their use in treating pain | |
| Kogan et al. | Early oral analgesia after fast-track cardiac anesthesia | |
| WO2000009130A3 (en) | New pharmaceutical uses for nos inhibitors | |
| KR890014110A (en) | Medication | |
| ATE247965T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PARACETAMOL AND BUSPIRONE HAVING ANALGESIC EFFECT | |
| Innes et al. | Basic pharmacology and advances in emergency medicine | |
| DiPalma et al. | Management of low back and neck pain by analgesics and adjuvant drugs: an update | |
| Kewitz | Rare but serious risks associated with non-narcotic analgesics: clinical experience |